Author: Stan

RNS Number : 1190N Redx Pharma plc 18 May 2020   REDX PHARMA PLC (“Redx” or “the Company”)   Appointment of Non-Executive Director with Deep Experience of the Biotechnology Industry and Capital Markets   Alderley Park, 18 May 2020 Redx Pharma (AIM:REDX), the drug discovery and development company focused on cancer and fibrosis, is pleased...

RNS Number : 1272N Midatech Pharma PLC 18 May 2020   18 May 2020   The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 (“MAR”). With the publication of this announcement via a Regulatory Information Service, this inside information...

RNS Number : 1249N eEnergy Group PLC 18 May 2020   18 May 2020 eEnergy Group plc (“eEnergy” or “the Group”)   Launch of new COVID-19 package for Schools   In addition to providing a switch to LED lighting for no upfront investment, eLight will help schools by supplying a sanitisation service and a payment...

RNS Number : 1239N Directa Plus PLC 18 May 2020   18 May 2020   Directa Plus plc (“Directa Plus” or the “Company”)   Technology Innovation Award from Frost & Sullivan for Grafysorber   Directa Plus (AIM: DCTA), a leading producer and supplier of graphene nanoplatelets based products for use in consumer and industrial markets,...

RNS Number : 1267N e-Therapeutics plc 18 May 2020   e-therapeutics PLC   COVID-19 update: experimental testing initiated with WuXi AppTec     Oxford, UK, 18 May 2020 – e-therapeutics plc (AIM: ETX.L, “e-therapeutics” or “the Company”) today announces the initiation of experimental testing on the first set of compounds for the treatment of COVID-19...

RNS Number : 1235N Bacanora Lithium PLC 18 May 2020   18 May 2020 Bacanora Lithium plc (“Bacanora” or the “Company”)                                                                                            Notice of AGM   Bacanora Lithium plc (AIM: BCN), a lithium exploration and development company, is pleased to announce that the Company’s Annual General Meeting (“AGM”) will be held at The Clubhouse,...

RNS Number : 1282N Open Orphan PLC 18 May 2020   18 May 2020   Open Orphan plc (“Open Orphan” or the “Company”)  Update on antibody test agreement and recent share price movement Open Orphan plc (ORPH) the rapidly growing specialist CRO pharmaceutical services company which has a focus on orphan drugs and is the...

RNS Number : 1221N Block Energy PLC 18 May 2020   18 May 2020 Block Energy Plc (“Block Energy” or the “Company”) Posting of Annual Report & Accounts and Notice of AGM Further to the publication on 30 April 2020 of its final results for the 18 months period ending 31 December 2019, the Company’s...

RNS Number : 1223N Diaceutics PLC 18 May 2020   Diaceutics PLC (“Diaceutics” or the “Company”)   Update on Diagnostic Network for Precision Medicine   -      Diaceutics names its Nexus platform ‘DXRX – The Diagnostic Network™’ -      It will be launched in Q4 2020 -      DXRX puts 2500+ laboratories at the centre of a precision...

RNS Number : 1264N Ergomed plc 18 May 2020   RNS REACH PRESS RELEASE     Ergomed Enters Strategic Collaboration to Drive Pharmacovigilance Leadership in Intelligent Automation   PrimeVigilance collaboration with Automation Anywhere and DataRobot to advance robotic processes and machine learning     Guildford, UK – 18 May 2020: Ergomed plc (LSE: ERGO) (‘Ergomed’...